• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802584
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/18/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that higher than expected vitros creatinine (crea) results were obtained from different samples from a single patient using vitros chemistry products crea slides lot 1525-3492-0523 on a vitros 5600 integrated system.The results were higher than expected when compared to non-vitros results (beckam coulter method) obtained at a reference laboratory.The likely assignable cause of the higher than expected vitros crea patient sample results is an interferent in the samples from the patient that affects the vitros crea assay.One potential interferent is creatine as the vitros crea ifu lists creatine as an interferent that will cause a dp flag for the vitros crea assay.According to the vitros crea instructions for use (ifu), a dp code indicates high background density, usually due to an elevated creatine concentration.The customer stated that the physician who questioned the crea results indicated that based on the patient medical history the patient was likely taking creatine.The vitros analyzer posted dp codes while testing the patient samples neat and subsequently performed several dilutions per the ifu before they obtained crea results within the assay measuring range.In addition, the patient was taking multiple medications at the time of the event and interference with those medications could not be ruled out as potential contributors to the event.Based on historical quality control results, a vitros crea lot 1525-3492-0523 performance issue is not a likely contributor to the event.Furthermore, continual tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros crea reagent lot 1525-3492-0523.Within run precision testing was not performed on the vitros 5600 integrated system.However, there was no evidence indicating that the vitros 5600 integrated system was a contributor to the event.Additionally, pre-analytical sample processing could not be ruled out as a contributing factor as the customer was not following the sample collection device manufacturer¿s recommended centrifugation protocol.Improper pre-analytical sample handling could have contributed to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.
 
Event Description
A customer obtained higher than expected vitros creatinine (crea) results from different samples from a single patient using vitros chemistry products crea slides lot 1525-3492-0523 on a vitros 5600 integrated system.The results were higher than expected when compared to non-vitros results (beckam coulter method) obtained at a reference laboratory.Patient sample 1 vitros crea result of 2.24 mg/dl versus an expected result of 1.14 mg/dl.Patient sample 2 vitros crea result of 1.53 mg/dl versus an expected result of 1.13 mg/dl.Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The higher than expected vitros crea results were reported from the laboratory.However, a physician questioned the results and no treatment was initiated, altered or stopped based on the higher than expected results.There was no allegation of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc (ortho).Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS CHEMISTRY PRODUCTS CREA SLIDES
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
513 technology blvd.
rochester NY 14652
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key9467129
MDR Text Key214628974
Report Number1319809-2019-00122
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 12/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2020
Device Catalogue Number6802584
Device Lot Number1525-3492-0523
Was Device Available for Evaluation? Yes
Date Manufacturer Received11/18/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/15/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-